GLPGF

Galapagos NV (GM) Stock Price


0.00 (0.0%)
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
VAT not included
Company Name Stock Ticker Symbol Market Type
Galapagos NV (GM) GLPGF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% -
Open Price Low Price High Price Close Price Previous Close
Last Trade Time Type Quantity Stock Price Currency
- 0 USD

Galapagos NV (GM) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.77B 26.77M - $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
261.87k $ - 0.00% - -

more financials information »

Galapagos NV (GM) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GLPGF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week124.00125.20124.00124.001150.000.0%
1 Month128.00128.00114.00125.25490.000.0%
3 Months132.0148143.00114.00131.18840.000.0%
6 Months194.00208.7596114.00140.973030.000.0%
1 Year195.4497276.21114.00216.453,4170.000.0%
3 Years90.1576276.2190.1576195.703,7450.000.0%
5 Years48.50276.2138.40142.823,7830.000.0%

Galapagos NV (GM) Description

Galapagos is a midsized biotechnology company, with therapeutic programs based on proprietary disease modifying drug targets, and a focus on inflammation, orphan disease, and anti-infectives. Galapagos' approach is to develop drugs that stop or reverse a disease state using novel targets that are identified through a patent protected target discovery platform. Galapagos also provides access to its target and drug discovery platform through its services division, BioFocus and Argenta, which offers a full suite of target-to-drug discovery products and services to pharmaceutical and biotech companies.


Your Recent History
USOTC
GLPGF
Galapagos ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.